Professor Christopher Scott
Chris’s research focuses on the development of new antibody and nano-medicine based approaches for the treatment of cancer. His group also works extensively on understanding the complex milieu of the tumour microenvironment, and in particular protease species that are up-regulated in aggressive and metastatic tumours.
We are interested in hosting visiting researchers and PhD students with an interest in; nanomedicine, antibody therapeutics, proteases and pancreatic cancer
Proteases and pancreatic cancer
PUBLIC OUTREACH AND KEY ACHIEVEMENTS
The Graduate School
Our dedicated hub for postgraduate students, providing state-of-the-art facilities for study, and high-quality training and development programmes within a diverse interdisciplinary community.The gateway to your postgraduate experience